These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34298950)

  • 41. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.
    Huang SM; Mishina YM; Liu S; Cheung A; Stegmeier F; Michaud GA; Charlat O; Wiellette E; Zhang Y; Wiessner S; Hild M; Shi X; Wilson CJ; Mickanin C; Myer V; Fazal A; Tomlinson R; Serluca F; Shao W; Cheng H; Shultz M; Rau C; Schirle M; Schlegl J; Ghidelli S; Fawell S; Lu C; Curtis D; Kirschner MW; Lengauer C; Finan PM; Tallarico JA; Bouwmeester T; Porter JA; Bauer A; Cong F
    Nature; 2009 Oct; 461(7264):614-20. PubMed ID: 19759537
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Loganathan L; Muthusamy K; Jayaraj JM; Kajamaideen A; Balthasar JJ
    J Biomol Struct Dyn; 2019 Sep; 37(14):3637-3648. PubMed ID: 30204055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer.
    Yakkala PA; Naaz F; Shafi S; Kamal A
    Expert Opin Ther Targets; 2024 Mar; 28(3):159-177. PubMed ID: 38497299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. WIKI4, a novel inhibitor of tankyrase and Wnt/ß-catenin signaling.
    James RG; Davidson KC; Bosch KA; Biechele TL; Robin NC; Taylor RJ; Major MB; Camp ND; Fowler K; Martins TJ; Moon RT
    PLoS One; 2012; 7(12):e50457. PubMed ID: 23227175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells.
    Kulak O; Chen H; Holohan B; Wu X; He H; Borek D; Otwinowski Z; Yamaguchi K; Garofalo LA; Ma Z; Wright W; Chen C; Shay JW; Zhang X; Lum L
    Mol Cell Biol; 2015 Jul; 35(14):2425-35. PubMed ID: 25939383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of tankyrase and peroxiredoxin II is indispensable for the survival of colorectal cancer cells.
    Kang DH; Lee DJ; Lee S; Lee SY; Jun Y; Kim Y; Kim Y; Lee JS; Lee DK; Lee S; Jho EH; Yu DY; Kang SW
    Nat Commun; 2017 Jun; 8(1):40. PubMed ID: 28659575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines.
    Thomson DW; Wagner AJ; Bantscheff M; Benson RE; Dittus L; Duempelfeld B; Drewes G; Krause J; Moore JT; Mueller K; Poeckel D; Rau C; Salzer E; Shewchuk L; Hopf C; Emery JG; Muelbaier M
    J Med Chem; 2017 Jul; 60(13):5455-5471. PubMed ID: 28591512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tankyrase inhibition sensitizes cells to CDK4 blockade.
    Foronda M; Tarumoto Y; Schatoff EM; Leach BI; Diaz BJ; Zimmerman J; Goswami S; Shusterman M; Vakoc CR; Dow LE
    PLoS One; 2019; 14(12):e0226645. PubMed ID: 31891587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The ADP-ribose polymerase Tankyrase regulates adult intestinal stem cell proliferation during homeostasis in Drosophila.
    Wang Z; Tian A; Benchabane H; Tacchelly-Benites O; Yang E; Nojima H; Ahmed Y
    Development; 2016 May; 143(10):1710-20. PubMed ID: 27190037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wnt/Wingless Pathway Activation Is Promoted by a Critical Threshold of Axin Maintained by the Tumor Suppressor APC and the ADP-Ribose Polymerase Tankyrase.
    Wang Z; Tacchelly-Benites O; Yang E; Thorne CA; Nojima H; Lee E; Ahmed Y
    Genetics; 2016 May; 203(1):269-81. PubMed ID: 26975665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human Cytomegalovirus Inhibits the PARsylation Activity of Tankyrase--A Potential Strategy for Suppression of the Wnt Pathway.
    Roy S; Liu F; Arav-Boger R
    Viruses; 2015 Dec; 8(1):. PubMed ID: 26729153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tankyrase Inhibition Causes Reversible Intestinal Toxicity in Mice with a Therapeutic Index < 1.
    Zhong Y; Katavolos P; Nguyen T; Lau T; Boggs J; Sambrone A; Kan D; Merchant M; Harstad E; Diaz D; Costa M; Schutten M
    Toxicol Pathol; 2016 Feb; 44(2):267-78. PubMed ID: 26692561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crystal structure of a Tankyrase-Axin complex and its implications for Axin turnover and Tankyrase substrate recruitment.
    Morrone S; Cheng Z; Moon RT; Cong F; Xu W
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1500-5. PubMed ID: 22307604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
    Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tankyrase is necessary for canonical Wnt signaling during kidney development.
    Karner CM; Merkel CE; Dodge M; Ma Z; Lu J; Chen C; Lum L; Carroll TJ
    Dev Dyn; 2010 Jul; 239(7):2014-23. PubMed ID: 20549720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unravelling the Mechanistic Role of Quinazolinone Pharmacophore in the Inhibitory Activity of Bis-quinazolinone Derivative on Tankyrase-1 in the Treatment of Colorectal Cancer (CRC) and Non-small Cell Lung Cancer (NSCLC): A Computational Approach.
    Okunlola FO; Akawa OB; Subair TI; Omolabi KF; Soliman MES
    Cell Biochem Biophys; 2022 Mar; 80(1):1-10. PubMed ID: 34453681
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Liu J; Feng K; Ren Y
    J Biomol Struct Dyn; 2019 Sep; 37(14):3803-3821. PubMed ID: 30261821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macrocyclized Extended Peptides: Inhibiting the Substrate-Recognition Domain of Tankyrase.
    Xu W; Lau YH; Fischer G; Tan YS; Chattopadhyay A; de la Roche M; Hyvönen M; Verma C; Spring DR; Itzhaki LS
    J Am Chem Soc; 2017 Feb; 139(6):2245-2256. PubMed ID: 28084734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines.
    Stratford EW; Daffinrud J; Munthe E; Castro R; Waaler J; Krauss S; Myklebost O
    Cancer Med; 2014 Feb; 3(1):36-46. PubMed ID: 24403055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination Treatment of Polo-Like Kinase 1 and Tankyrase-1 Inhibitors Enhances Anticancer Effect in Triple-negative Breast Cancer Cells.
    Ha GH; Kim DY; Breuer EK; Kim CK
    Anticancer Res; 2018 Mar; 38(3):1303-1310. PubMed ID: 29491053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.